Inventage Lab (XKRX:389470) Debt-to-Equity : 0.00 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Inventage Lab Debt-to-Equity?

Inventage Lab's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩0.0 Mil. Inventage Lab's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩0.0 Mil. Inventage Lab's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩6,929.7 Mil. Inventage Lab's debt to equity for the quarter that ended in Mar. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Inventage Lab's Debt-to-Equity or its related term are showing as below:

XKRX:389470' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.09 Med: 0.16 Max: 6.07
Current: 1.55

During the past 5 years, the highest Debt-to-Equity Ratio of Inventage Lab was 6.07. The lowest was 0.09. And the median was 0.16.

XKRX:389470's Debt-to-Equity is ranked worse than
92.57% of 848 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs XKRX:389470: 1.55

Inventage Lab Debt-to-Equity Historical Data

The historical data trend for Inventage Lab's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventage Lab Debt-to-Equity Chart

Inventage Lab Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

-0.15

0.29

0.15

0.09

2.43

Inventage Lab Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial					0.09	0.30	6.07	2.43	-

Competitive Comparison of Inventage Lab's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Inventage Lab's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inventage Lab's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Inventage Lab's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Inventage Lab's Debt-to-Equity falls into.

Inventage Lab Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Inventage Lab's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4478.131	+	6236.167)	/	4410.628
	=	2.43

Inventage Lab's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	6929.715
	=	0.00

Inventage Lab (XKRX:389470) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Inventage Lab Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Inventage Lab's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Inventage Lab (XKRX:389470) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inventage Lab Inc (XKRX:389470) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

24, Dunchon-daero 388 beon-gil, 612, Woolim Lions Valley 3, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13403

Website

https://www.inventagelab.com

Inventage Lab Inc operates medical technology development businesses. It engages in the development of an innovative Drug Delivery System (DDS). It has developed Laminar FluiDigm, a microfluidics-based novel platform technology that builds the foundation for IVL- DrugFluidic and IVL-GeneFluidic, which are specific platform technologies used for developing and manufacturing long-acting injectables and gene-delivery therapeutics.

Inventage Lab (XKRX:389470) Headlines

No Headlines